Clinical Trials Logo

Filter by:
  • Not yet recruiting  
  • « Prev · Page [7]
NCT ID: NCT01001962 Not yet recruiting - Hypertension Clinical Trials

Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics

PREHYPD
Start date: January 2016
Phase: Phase 4
Study type: Interventional

Objectives: Primary 1. Primary prevention of new onset of hypertension Secondary 1. Reduction of 24h BP in type II diabetics with prehypertension 2. Reduction of non dipping status, day and nighttime BP, morning BP surge in subjects receiving EMPAGLIFLOZIN 3. Reduction in the total cardiovascular risk 4. 3 years morbidity and mortality rates 5. Arterial de-stiffening, reduction in central aortic blood pressure in subjects receiving EMPAGLIFLOZIN